Deutsche Märkte geschlossen

Avinger, Inc. (AVGR)

NasdaqCM - NasdaqCM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
3,8100+0,2200 (+6,13%)
Börsenschluss: 03:24PM EDT

Avinger, Inc.

400 Chesapeake Drive
Redwood City, CA 94063
United States
(650) 241-7900
https://avinger.com

Sektor(en)Healthcare
BrancheMedical Instruments & Supplies
Vollzeitmitarbeiter68

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Jeffrey M. SoinskiPresident, CEO & Director616,79kN/A1962
Mr. Nabeel P. SubainatiVP of Finance, Principal Financial Officer & Accounting Officer347,58kN/A1984
Mr. Himanshu N. PatelChief Technology Officer430,08kN/A1960
Mr. Keith SchaeferChief Operating OfficerN/AN/AN/A
Mr. Philip R. PreussChief Marketing Officer & VP of Business OperationsN/AN/A1978
Mr. Corey GibbsVice President of SalesN/AN/AN/A
Dr. Jaafer Golzar FACC, M.D.Chief Medical OfficerN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Corporate Governance

Avinger, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.